Skip to main content

CORRECTION article

Front. Immunol., 05 June 2024
Sec. NK and Innate Lymphoid Cell Biology
Volume 15 - 2024 | https://doi.org/10.3389/fimmu.2024.1439246

Corrigendum: NK cell subsets changes in partial remission and early stages of pediatric type 1 diabetes

This article is a correction to:

  1. NK Cell Subsets Changes in Partial Remission and Early Stages of Pediatric Type 1 Diabetes

    1. Read original article
Laia Gomez-MuozLaia Gomez-Muñoz1David Perna-BarrullDavid Perna-Barrull1Adrian VillalbaAdrian Villalba1Silvia Rodriguez-FernandezSilvia Rodriguez-Fernandez1Rosa-Maria AmpudiaRosa-Maria Ampudia1Aina Teniente-SerraAina Teniente-Serra1Federico VazquezFederico Vazquez2Marta MurilloMarta Murillo3Jacobo PerezJacobo Perez4Raquel CorripioRaquel Corripio4Joan BelJoan Bel3Marta Vives-Pi*Marta Vives-Pi1*
  • 1Immunology Service, Germans Trias i Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain
  • 2Endocrinology Service, Germans Trias i Pujol University Hospital, Badalona, Spain
  • 3Pediatrics Service, Germans Trias i Pujol University Hospital, Badalona, Spain
  • 4Department of Pediatric Endocrine, Parc Tauli Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí I3PT, Universitat Autonoma de Barcelona, Sabadell, Spain

A corrigendum on
NK cell subsets changes in partial remission and early stages of pediatric type 1 diabetes

by Gomez-Muñoz L, Perna-Barrull D, Villalba A, Rodriguez-Fernandez S, Ampudia RM, Teniente-Serra A, Vazquez F, Murillo M, Perez J, Corripio R, Bel J, Vives-Pi M. Front Immunol. 11:611522. doi: 10.3389/fimmu.2020.611522

In the published article, there was an error in the Funding statement. The Funding statement was displayed as “This work has been funded by the Spanish Government (FIS PI18/00436) co-financed with the European Regional Development funds (FEDER), and by DiabetesCero Foundation.”. The correct Funding statement appears below.

FUNDING

This study has been funded by Instituto de Salud Carlos III through the project PI18/00436 (Co-funded by European Regional Development Fund ‘A way to make Europe’), and by DiabetesCero Foundation.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: NK cell subpopulations, type 1 diabetes, partial remission, pediatrics, autoimmunity

Citation: Gomez-Muñoz L, Perna-Barrull D, Villalba A, Rodriguez-Fernandez S, Ampudia R-M, Teniente-Serra A, Vazquez F, Murillo M, Perez J, Corripio R, Bel J and Vives-Pi M (2024) Corrigendum: NK cell subsets changes in partial remission and early stages of pediatric type 1 diabetes. Front. Immunol. 15:1439246. doi: 10.3389/fimmu.2024.1439246

Received: 27 May 2024; Accepted: 28 May 2024;
Published: 05 June 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Gomez-Muñoz, Perna-Barrull, Villalba, Rodriguez-Fernandez, Ampudia, Teniente-Serra, Vazquez, Murillo, Perez, Corripio, Bel and Vives-Pi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Marta Vives-Pi, mvives@igtp.cat

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.